Skip to content

Robert Harry Karl, M.D.

NPI 1598728404ActiveIndividual· Specialist· Miami, FL

Specialist (M.D.) in Miami, Florida, licensed in FL, with an NPI issued in April 2006. Part D covered 52 prescriptions written in 2024, 77% of them generic. Novartis Pharmaceuticals Corporation reported $15.53 in payments in 2025, mostly food and beverage.

Overview

NPI1598728404
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorNo
NPI issuedApr 11, 2006
Last updated in NPPESJul 13, 2026

Specialties and licenses

TaxonomyCodeLicenseState
Specialist Primary174400000XME0022811FL

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Cardiovascular Disease (Cardiology) (FL)

Part D prescriptions in 2024

Prescriptions (claims)52 · 134 30-day fills
Total drug cost$17,740
Generic share77% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$15.53 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Novartis Pharmaceuticals Corporation$15.531

What the 2025 payments were for

  • Food and Beverage$15.53 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Specialist providers in Miami

All 541 Specialist providers in Miami · All Specialist providers in Florida